The Office of the U.S. Trade Representative (USTR) has announced that it will continue to exclude Section 301 duties on imports of certain Chinese medical care products needed to address the COVID-19 pandemic. The current exclusions were set to expire on March 31, 2021 (see Update of December 23, 2020); however, with this announcement, the exclusions will continue until September 30, 2021.

The exclusions cover a variety of Chinese medical care products, including but not limited to: face shields; certain sterile drapes and covers; gloves; face masks; hot and cold packs; otoscopes; certain woven gauze sponges; certain non-woven fabrics; certain microscopes; certain dispensers and hand pumps for liquids; certain plastic aprons for personal protection; certain molded acrylonitrile-butadiene-styrene (ABS) tubes; certain adhesive polyethylene films, sheets and strips; and certain parts and components for X-ray and MRI equipment. These exclusions are available for any product that meets the description in the annexes accompanying the USTR announcement. The scope of each exclusion is determined by the 10-digit Harmonized Tariff Schedule subheadings and the product descriptions in the annexes.